Chris Storgard Selected Research

Heat-Shock Proteins (Heat-Shock Protein)

9/2013

Phase I study of BIIB028, a selective heat shock protein 90 inhibitor, in patients with refractory metastatic or locally advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chris Storgard Research Topics

Disease

9	Gout 12/2017 - 01/2015
2	Renal Insufficiency (Renal Failure) 06/2016 - 01/2016
2	Neoplasms (Cancer) 09/2013 - 01/2005
1	Headache (Headaches) 06/2016
1	Nasopharyngitis 06/2016
1	Arthralgia (Joint Pain) 06/2016
1	Chronic Renal Insufficiency 01/2016
1	Hypersensitivity (Allergy) 10/2015
1	Exanthema (Rash) 10/2015

Drug/Important Bio-Agent (IBA)

7	Uric Acid (Urate)IBA 12/2017 - 01/2015
6	lesinuradIBA 12/2017 - 01/2015
5	Allopurinol (Remid)FDA LinkGeneric 05/2017 - 10/2015
2	Xanthine OxidaseIBA 12/2017 - 01/2017
2	Febuxostat FDA Link 01/2017 - 01/2016
2	CreatinineIBA 06/2016 - 01/2016
1	Colchicine FDA LinkGeneric 06/2016
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2013

Therapy/Procedure

5	Therapeutics 05/2017 - 10/2015
1	Contraindications 12/2017
1	Topical Administration 01/2005